31-45 of 872
New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
NephrologyNew Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes
The Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
NephrologyThe Impact of Finerenone Plus Empagliflozin on Hyperkalemia in the CONFIDENCE Trial
PREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
Heart MattersPREVENT vs PCE: Refining ASCVD Risk Prediction in Statin-Treated Populations
The LDL-C Gap in Statin-Treated Patients: A Population-Level Problem with Economic Consequences
Heart MattersThe LDL-C Gap in Statin-Treated Patients: A Population-Level Problem with Economic Consequences
Reframing Monotherapy and Combination Strategies for Hyperlipidemia
Heart MattersReframing Monotherapy and Combination Strategies for Hyperlipidemia
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living RheumUnderstanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
- advertisement
Managing Genotype-Positive Patients in Hereditary ATTR-CM
On the Frontlines of ATTR-CMManaging Genotype-Positive Patients in Hereditary ATTR-CM
The Cost of Progress: Examining Barriers to ATTR-CM Care
On the Frontlines of ATTR-CMThe Cost of Progress: Examining Barriers to ATTR-CM Care
Understanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
Heart MattersUnderstanding Lipid and Lipoprotein Metabolism in Cardiovascular Health
How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
FCDC Action CenterHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Heart MattersDiagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Heart MattersATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
- advertisement
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
On the Frontlines of ATTR-CMVutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
Sex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
Heart MattersSex-Based Differences in Lipid Management: Implications for Cardiovascular Risk
Gender Bias and Heart Health: Improving Cardiovascular Care for Women
Heart MattersGender Bias and Heart Health: Improving Cardiovascular Care for Women
